These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 18629507)

  • 1. [Patient reported outcomes. Relevance and application in ophthalmology].
    Finger RP; Scholl HP; Holz FG
    Ophthalmologe; 2008 Aug; 105(8):722-6. PubMed ID: 18629507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Introduction to the topic: quality of life in ophthalmology].
    Finger RP; Holz FG
    Ophthalmologe; 2008 Aug; 105(8):721. PubMed ID: 18607600
    [No Abstract]   [Full Text] [Related]  

  • 3. [Evaluation of the quality of life in ophthalmology].
    Brémond-Gignac D; Tixier J; Missotten T; Laroche L; Beresniak A
    Presse Med; 2002 Oct; 31(34):1607-12. PubMed ID: 12426979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Quality of life - methodology and clinical practice aspects with a focus on ocular medicine].
    Franke GH; Gall C
    Ophthalmologe; 2008 Aug; 105(8):727-34. PubMed ID: 18629506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Classical Medical Mistakes - Lack of Appreciation of Psychological Components].
    Burggraf MH
    Klin Monbl Augenheilkd; 2018 Mar; 235(3):315-318. PubMed ID: 28086249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measuring patient-reported outcomes in psychosis: conceptual and methodological review.
    Reininghaus U; Priebe S
    Br J Psychiatry; 2012 Oct; 201(4):262-7. PubMed ID: 23028084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of vision in everyday activities.
    Wood J; Rubin GS; Owsley C
    Ophthalmic Physiol Opt; 2011 May; 31(3):201-2. PubMed ID: 21470271
    [No Abstract]   [Full Text] [Related]  

  • 9. Quality indicators for the care of vision impairment in vulnerable elders.
    Rowe S; MacLean CH
    J Am Geriatr Soc; 2007 Oct; 55 Suppl 2():S450-6. PubMed ID: 17910570
    [No Abstract]   [Full Text] [Related]  

  • 10. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Nonorganic disorders in ophthalmology: overview of diagnosis and therapy].
    Mojon DS; Schläpfer TE
    Klin Monbl Augenheilkd; 2001 May; 218(5):298-304. PubMed ID: 11417321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrating the patient's perspective into device evaluation trials.
    Leidy NK; Beusterien K; Sullivan E; Richner R; Muni NI
    Value Health; 2006; 9(6):394-401. PubMed ID: 17076870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of patient-reported outcomes in clinical trials: the example of health-related quality of life.
    Wiklund I
    Fundam Clin Pharmacol; 2004 Jun; 18(3):351-63. PubMed ID: 15147288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Impact of Visual Field Clusters on Performance-based Measures and Vision-Related Quality of Life in Patients With Glaucoma.
    Sun Y; Lin C; Waisbourd M; Ekici F; Erdem E; Wizov SS; Hark LA; Spaeth GL
    Am J Ophthalmol; 2016 Mar; 163():45-52. PubMed ID: 26701273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of an intervention to support hearing and vision in dementia: The SENSE-Cog Field Trial.
    Leroi I; Simkin Z; Hooper E; Wolski L; Abrams H; Armitage CJ; Camacho E; Charalambous AP; Collin F; Constantinidou F; Dawes P; Elliott R; Falkingham S; Frison E; Hann M; Helmer C; Himmelsbach I; Hussain H; Marié S; Montecelo S; Thodi C; Yeung WK
    Int J Geriatr Psychiatry; 2020 Apr; 35(4):348-357. PubMed ID: 31713262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A survey of eye and vision care in Oklahoma.
    Walls LL; March J; Lapolla M
    J Am Optom Assoc; 1993 Nov; 64(11):799-808. PubMed ID: 8120334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measuring treatment impact: a review of patient-reported outcomes and other efficacy endpoints in approved product labels.
    Willke RJ; Burke LB; Erickson P
    Control Clin Trials; 2004 Dec; 25(6):535-52. PubMed ID: 15588741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using patient-reported outcomes in routine practice: three novel use cases and implications.
    Forsberg HH; Nelson EC; Reid R; Grossman D; Mastanduno MP; Weiss LT; Fisher ES; Weinstein JN
    J Ambul Care Manage; 2015; 38(2):188-95. PubMed ID: 25748267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The benefits of using patient-reported outcomes in cancer treatment: an overview].
    Wintner LM; Giesinger JM; Kemmler G; Sztankay M; Oberguggenberger A; Gamper EM; Sperner-Unterweger B; Holzner B
    Wien Klin Wochenschr; 2012 May; 124(9-10):293-303. PubMed ID: 22538839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age-related eye disease, quality of life, and functional activity.
    Knudtson MD; Klein BE; Klein R; Cruickshanks KJ; Lee KE
    Arch Ophthalmol; 2005 Jun; 123(6):807-14. PubMed ID: 15955982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.